Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 7156928, 7 pages
https://doi.org/10.1155/2017/7156928
Research Article

Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer’s Disease Patients

1Department of Biology, Faculty of Biology, “Alexandru Ioan Cuza” University of Iasi, Carol I Avenue, 20A, 700505 Iasi, Romania
2Department of Research, Faculty of Biology, “Alexandru Ioan Cuza” University of Iasi, Carol I Avenue, 20A, 700505 Iasi, Romania
3Department of Psychiatry, Faculty of Medicine, “Gr. T. Popa” University of Medicine and Pharmacy, 16th University Avenue, 700115 Iasi, Romania

Correspondence should be addressed to Alin Ciobica; or.ciau@aciboic.nila

Received 25 March 2017; Revised 28 June 2017; Accepted 2 July 2017; Published 24 July 2017

Academic Editor: Mario Barbagallo

Copyright © 2017 Ioana-Miruna Balmuș et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. Anderson, D. Darshan, S. J. Wilkins, and D. M. Frazer, “Regulation of systemic iron homeostasis: how the body responds to changes in iron demand,” Biometals, vol. 20, p. 665, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Grubman, E. Pollari, C. Duncan et al., “Deregulation of biometal homeostasis: the missing link for neuronal ceroid lipofuscinoses?” Metallomics, vol. 6, no. 4, pp. 932–943, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kolisek, A. C. Montezano, G. Sponder et al., “PARK7/DJ-1 dysregulation by oxidative stress leads to magnesium deficiency: implications in degenerative and chronic diseases,” Clinical Science, vol. 129, no. 12, pp. 1143–1150, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Y. Lee, E. Cho, T. Y. Kim et al., “Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain,” Biometals, vol. 23, no. 6, pp. 1085–1095, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Takeda and H. Tamano, “Cognitive decline due to excess synaptic Zn2+ signaling in the hippocampus,” Frontiers in Aging Neuroscience, vol. 6, p. 26, 2014. View at Google Scholar
  6. K. Iqbal and I. Grundke-Iqbal, “Alzheimer disease, a multifactorial disorder seeking multi-therapies,” Alzheimer’s & Dementia, vol. 6, no. 5, pp. 420–424, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Alkadhi and J. Eriksen, “The complex and multifactorial nature of Alzheimer’s disease,” Current Neuropharmacology, vol. 9, no. 4, p. 586, 2011. View at Publisher · View at Google Scholar
  8. M. C. Carreiras, E. Mendes, M. J. Perry, A. P. Francisco, and J. Marco-Contelles, “The multifactorial nature of Alzheimer’s disease for developing potential therapeutics,” Current Topics in Medicinal Chemistry, vol. 13, no. 15, pp. 1745–1770, 2013. View at Publisher · View at Google Scholar
  9. J. K. Morris, R. A. Honea, E. D. Vidoni, R. H. Swerdlow, and J. M. Burns, “Is Alzheimer’s disease a systemic disease?” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1842, no. 9, pp. 1340–1349, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Boyle, R. S. Wilson, N. T. Aggarwal, Y. Tang, and D. A. Bennett, “Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline,” Neurology, vol. 67, no. 3, pp. 441–445, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Jomova and M. Valko, “Advances in metal-induced oxidative stress and human disease,” Toxicology, vol. 283, no. 2-3, pp. 65–87, 2011. View at Google Scholar
  12. J. Z. Lindeque, O. Levanets, R. Louw, and F. H. van der Westhuizen, “The involvement of metallothioneins in mitochondrial function and disease,” Current Protein and Peptide Science, vol. 11, pp. 292–309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Valko, D. Leibfritz, J. Moncol, M. T. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Gerber, F. Wu, M. Dimitrov, G. M. Garcia Osuna, and P. C. Fraering, “Zinc and copper differentially modulate amyloid precursor protein processing by γ-secretase and amyloid-β peptide production,” The Journal of Biological Chemistry, vol. 292, no. 9, pp. 3751–3767, 2017, Abstract. View at Publisher · View at Google Scholar
  15. E. Koseoglu, R. Koseoglu, M. Kendirci, R. Saraymen, and B. Saraymen, “Trace metal concentrations in hair and nails from Alzheimer’s disease patients: relations with clinical severity,” Journal of Trace Elements in Medicine and Biology, vol. 39, pp. 124–128, 2017. View at Publisher · View at Google Scholar
  16. M. Padurariu, A. Ciobica, L. Hritcu, B. Stoica, W. Bild, and C. Stefanescu, “Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease,” Neuroscience Letters, vol. 469, no. 1, pp. 6–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Padurariu, A. Ciobica, R. Lefter, I. L. Serban, C. Stefanescu, and R. Chirita, “The oxidative stress hypothesis in Alzheimer’s disease,” Psychiatria Danubina, vol. 25, no. 4, pp. 401–409, 2013. View at Google Scholar
  18. R. C. Mohs, W. G. Rosen, and K. L. Davis, “The Alzheimer’s disease assessment scale: an instrument for assessing treatment efficacy,” Psychopharmacology Bulletin, vol. 19, pp. 448–450, 1983. View at Google Scholar
  19. B. Rosen, R. C. Mohs, and K. L. Davis, “A new rating scale for Alzheimer’s disease,” American Journal of Psychiatry, vol. 141, pp. 1356–1364, 1984. View at Publisher · View at Google Scholar
  20. G. McKhan, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan, “Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force of Alzheimer’s disease,” Neurology, vol. 34, pp. 939–944, 1984. View at Publisher · View at Google Scholar
  21. B. J. Kelley and D. S. Knopman, “Alternative medicine and Alzheimer disease,” The Neurologist, vol. 14, pp. 299–306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, “Mild cognitive impairment: clinical characterization and outcome,” Archives of Neurology, vol. 56, pp. 303–308, 1999. View at Publisher · View at Google Scholar
  23. S. A. Strungaru, M. Nicoara, O. Jitar, and G. Plavan, “Influence of urban activity in modifying water parameters, concentration and uptake of heavy metals in Typha latifolia L. into a river that crosses an industrial city,” Journal of Environmental Health Science and Engineering, vol. 13, p. 5, 2015. View at Google Scholar
  24. S. Phelps and W. Harris, “Garlic supplementation and lipoprotein oxidation susceptibility,” Lipids, vol. 28, no. 5, pp. 475–477, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Truţia, Biochimie medicală. Manual de laborator, Tehnoplast Company, Bucureşti, 1999.
  26. S. Gao, Y. Jin, F. W. Unverzagt et al., “Trace element levels and cognitive function in rural elderly Chinese,” Biological Sciences Section of the Journals of Gerontology, Series A, vol. 63, no. 6, pp. 635–641, 2008. View at Google Scholar
  27. M. Farina, D. Silva Avila, J. Batista Teixeira da Rocha, and M. Aschn, “Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury,” Neurochemistry International, vol. 62, no. 5, pp. 575–594, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Barbagallo, M. Belvedere, G. D. Bella, and L. J. Dominguez, “Altered ionized magnesium levels in mild-to-moderate Alzheimer’s disease,” Magnesium Research, vol. 24, no. 3, pp. S115–S121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. E. Cilliler, S. Ozturk, and S. Ozbakir, “Serum magnesium level and clinical deterioration in Alzheimer’s disease,” Gerontology, vol. 53, no. 6, pp. 419–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Du, M. Liu, Y. Pan, X. Zhong, and M. Wei, “Association of serum manganese levels with Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis,” Nutrients, vol. 9, p. 231, 2017. View at Publisher · View at Google Scholar
  31. Z. X. Wang, L. Tan, H. F. Wang et al., “Serum iron, zinc, and copper levels in patients with Alzheimer’s disease: a replication study and meta-analyses,” Journal of Alzheimer’s Disease, vol. 47, no. 3, pp. 565–581, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Paglia, O. Miedico, A. Cristofano et al., “Distinctive pattern of serum elements during the progression of Alzheimer’s disease,” Scientific Reports, vol. 6, article 22769, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Aybek, F. Ercan, D. Aslan, and T. Sahiner, “Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli,” Journal of Turkish Clinical Biochemistry, vol. 40, pp. 172–176, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Baldeiras, I. Santana, M. T. Proença et al., “Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer’s disease,” Journal of Alzheimer’s Disease, vol. 15, pp. 117–128, 2008. View at Publisher · View at Google Scholar
  35. E. M. Kawamoto, C. D. Munhoz, I. Glezer et al., “Oxidative state in platelets and erythrocytes in aging and Alzheimer’s disease,” Neurobiology and Aging, vol. 26, pp. 857–864, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. R. A. Webster, ““Alzheimer’s disease”, chapter 18, in section C “neurotransmitters in drug actions and disease states”,” in Neurotransmitters, Drugs and Brain Function, R. A. Webster, Ed., John Wiley & Sons, 2001. View at Google Scholar
  37. L. L. Torres, N. B. Quaglio, G. T. d. Souza et al., “Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease,” Journal of Alzheimer’s Disease, vol. 26, no. 1, pp. 59–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Cervellati, A. Romani, D. Seripa et al., “Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment,” BioMed Research International, vol. 2014, Article ID 309507, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Swomley and A. D. Butterfield, “Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics,” Archives of Toxicology, vol. 89, no. 10, pp. 1669–1680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Smith, X. Zhu, M. Tabaton et al., “Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment,” Journal of Alzheimer’s Disease, vol. 19, no. 1, pp. 363–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. D. J. Hare, J. D. Doecke, N. G. Faux et al., “Decreased plasma iron in Alzheimer’s disease is due to transferrin desaturation,” American Chemical Society Chemical Neuroscience, vol. 6, no. 3, pp. 398–402, 2015. View at Google Scholar
  42. P. Martorell, S. Llopis, N. Gonzalez et al., “A nutritional supplement containing lactoferrin stimulates the immune system, extends lifespan, and reduces amyloid β peptide toxicity in Caenorhabditis elegans,” Food Science & Nutrition, vol. 5, no. 2, pp. 255–265, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Tong, H. Yang, X. Tian et al., “High manganese, a risk for Alzheimer’s disease: high manganese induces amyloid-β related cognitive impairment,” Journal of Alzheimer’s Disease, vol. 42, no. 3, pp. 865–878, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. T. V. Peres, H. Eyng, S. C. Lopes et al., “Developmental exposure to manganese induces lasting motor and cognitive impairment in rats,” Neurotoxicology, vol. 50, pp. 28–37, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Esposito, J. Raber, L. Kekonius et al., “Reduction in mitochondrial superoxide dismutase modulates Alzheimer’s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice,” Journal of Neuroscience, vol. 26, no. 19, pp. 5167–5179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. D. L. Marcus, J. A. Strafaci, and M. L. Freedman, “Differential neuronal expression of manganese superoxide dismutase in Alzheimer’s disease,” Medical Science Monitor, vol. 12, no. 1, pp. 8–14, 2006. View at Google Scholar
  47. A. W. Dobson and M. Aschner, “Manganese-induced oxidative stress,” in Oxidative Stress and Neurodegenerative Disorders, Chapter 19, G. Ali Qureshi and S. Hasan Parvez, Eds., p. 433, Elsevier, 2007. View at Google Scholar
  48. J. L. Glick, “Dementias: the role of magnesium deficiency and an hypothesis concerning the pathogenesis of Alzheimer’s disease,” Medical Hypotheses, vol. 31, no. 3, pp. 211–225, 1990. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Durlach, “Magnesium depletion and pathogenesis of Alzheimer’s disease,” Magnesium Research, vol. 3, no. 3, pp. 217-218, 1990. View at Google Scholar
  50. W. Li, J. Yu, Y. Liu et al., “Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer’s disease mouse model,” Molecular Brain, vol. 7, p. 65, 2014. View at Google Scholar
  51. Z.-P. Xu, L. Li, J. Bao et al., “Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model,” PloS One, vol. 9, no. 9, article e108645, 2014. View at Google Scholar